Scroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...

Danish drugmaker Novo Nordisk is working to bring its blockbuster drug Ozempic to India “as soon as possible", Dr Yan Cai, ...

For some people, medication will be a tool to improve weight and insulin-related outcomes. For others, food alone is a ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Two of the distinguished in the latest edition of the Fronteras del Conocimiento FBBVA, endocrinologist Daniel J. Drucker and ...

Novo Nordisk dropped a pile of scientific data on three new experimental weight-loss drugs, including an oral one, showing ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.